Recent Quotes (30 days)

You have no recent quotes
chg | %

Vivione Biosciences Inc  

(Public, CVE:VBI.H)   Watch this stock  
Find more results for CVE:VBI
0.00000 (0.00%)
Jun 17 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 0.17
Open     -
Vol / Avg. 0.00/2,870.00
Mkt cap 199,590.00
P/E 0.13
Div/yield     -
EPS 0.04
Shares 40.19M
Beta     -
Inst. own     -

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin - 625.78%
Operating margin - -816.30%
EBITD margin - -715.85%
Return on average assets 33.56% 187.95%
Return on average equity 34.02% -
CDP Score - -


34-161 Hoadley Road Pine Bluff Arsenal
United States - Map
+1-214-8865733 (Phone)
+1-509-5617287 (Fax)

Website links


Vivione Biosciences Inc. (Vivione) is an early-stage biosciences company. The Company is a rapid bacteria detection company that has a technology to address some of the global challenges, including energy production, infectious disease detection and treatment, and food safety and security. The Company is a biosciences company focused on the commercialization of its RAPID-B system, an integrated system of hardware, software and chemical reagents that identifies, quantifies and qualifies bacteria in food safety, clinical, bio-therapeutics, and oil and gas environments. Vivione Biosciences, LLC (VivioneLLC) is a wholly owned subsidiary of the Company.

Officers and directors

Kevin Kuykendall Chief Executive Officer, Director
Chester J. Jachimiec Chief Financial Officer
Steve Roon Senior Vice President - Sales and Marketing
James Hendren Director
Glenn William Vincent Smith Director
Philip A. Tuttle Director
Age: 72
Ian E. Gallie Independent Director